Castle Biosciences
CSTL
CSTL
148 hedge funds and large institutions have $502M invested in Castle Biosciences in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 63 increasing their positions, 37 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
1.03% less ownership
Funds ownership: 84.15% → 83.12% (-1%)
3% less funds holding
Funds holding: 153 → 148 (-5)
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
Holders
148
Holding in Top 10
3
Calls
$686K
Puts
$5K
Top Buyers
| 1 | +$8.55M | |
| 2 | +$3.83M | |
| 3 | +$3.63M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.54M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.6M |
Top Sellers
| 1 | -$7.43M | |
| 2 | -$5.87M | |
| 3 | -$5.51M | |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$2.52M |
| 5 |
Goldman Sachs
New York
|
-$2.48M |